Faculty Information - Shin Ohira

Present specialized field

Journal

Presentation

（Last updated : 2024-10-02 12:47:26）

Shin Ohira
Department Kawasaki Medical School Kawasaki Medical School, Department of Urology,

Position Assistant Professor

■ Present specialized field

Urology, Medical management and medical sociology, Infectious disease medicine

■ Journal

1.	2023/02/09	Summary of the clinical practice manual for late-onset hypogonadism
2.	2022/12/19	Preventive effect of indoleamine 2,3-dioxygenase 1 inhibition on lipopolysaccharide-induced prostatitis
3.	2022/12/09	Pathophysiological analysis of detrusor overactivity following partial bladder outlet obstruction
4.	2022/12/06	Pathological analysis of spermatic dysfunction following testicular ischemia-reperfusion injury
5.	2022/12	The Urinary Bladder is Rich in Glycosphingolipids Composed of Phytoceramides
6.	2022/09/12	Changes in serum antibody titers after vaccination for COVID-19 and evaluation of post-vaccination health conditions
7.	2022/02/21	An in vitro system for experimentally induced cryptorchidism
8.	2022/01/19	Anti-inflammatory effect of tadalafil, a phosphodiesterase 5 (PDE5) inhibitor, in autoimmune prostatitis
9.	2022/01/12	Comprehensive analysis of cytokines in the follicular fluid and serum during in vitro fertilization and embryo transfer
10.	2022	Real‑world analysis of apalutamide‑associated skin adverse events in Japanese patients with advanced prostate cancer:a multi‑institutional study in the Chu‑shikoku Japan Urological Consortium
11.	2020	Outcomes of robot-assisted partial nephrectomy in the treatment of renal cell carcinoma at Kawasaki Medical School Hostiptal
12.	2019/03	Intra-abdominal desmoid tumor mimicking local recurrence of renal cell carcinoma after laparoscopic partial nephrectomy.
13.	2018/06	The role of indoleamine 2,3-dioxygenase (IDO) in epididymitis
14.	2018/04	Foreign Body in the Bladder: A Case Report
15.	2018	Male squirting: Analysis of one case using color Doppler ultrasonography
16.	2017/08	Long-term compliance and treatment failure of alpha1-blocker for patients with benign prostatic hyperplasia
17.	2015/06	Practical application of color Doppler ultrasonography in patients with ejaculatory dysfunction
Display 5 items
Display all(17)

■ Presentation

1.	2017/03/24	Therapeutic effect of RIPK1 inhibitor in testicular ischemia-reperfusion （Speech，General）
2.	2017/05/12	Therapeutic effect of RIPK1 inhibitor in testicular ischemia-reperfusion （Poster notice，General）
3.	2018/04/19	The role of indoleamine 2,3-dioxygenase (IDO) in prostatitis （Speech，General）
4.	2016/05/07	The role of indoleamine 2,3-dioxygenase in epididymitis （Speech，General）
5.	2018/09/20	Therapeutic effect of indoleamine 2,3-dioxygenase (IDO) inhibitor in the male genital inflammation （Speech）
6.	2016/03/12	The role of indoleamine 2,3-dioxygenase in epididymitis （Speech，General）
7.	2023/10	A Study on the continuity of drug treatment for benign prostatic hyperplasia （Poster notice，General）
8.	2023/10	Protective Effect of a Phosphodiesterase 5 Inhibitor on Age-Related Testicular Dysfunction （Poster notice，General）
9.	2021/11/20	Anti-inflammatory mechanism of indoleamine 2,3-dioxygenase 1 inhibition for autoimmune induced chronic prostatitis （Speech，Special/Invited Lecture）
10.	2021/11/19	Anti-inflammatory effect of indoleamine 2,3-dioxygenase 1 inhibition for lipopolysaccharide induced epididymitis （Speech，General）
11.	2021/11/19	Long-term outcomes of testosterone replacement therapy for patients with late-onset hypogonadism syndrome （Poster notice，General）
12.	2020/07	90 Anti-inflammatory effect of IDO1 inhibition for acute inflammation in the prostate （Poster notice，General）
13.	2020/07	New pathological subtype of renal cell carcinoma in patients on long-term dialysis: acquired cystic disease-associated renal cell carcinoma （General）
14.	2020/07	Pathological analysis focused on inflammatory changes in bladder dysfunction following partial bladder outlet obstruction （Poster notice，General）
15.	2019/11/09	Preventive effect of tadalafil for chronic inflammation in the prostate （Speech，General）
16.	2019/10/19	Renal Cell Carcinoma in Japanese Patients with End-Stage Renal Disease （Poster notice，General）
17.	2019/10/19	Validation of the Prostate Imaging and Reporting Data System Version 2(PI-RADS v2) for the detection of prostate cancer in Japanese men with elevated PSA Level. （Poster notice，General）
18.	2019/05/05	Therapeutic effect of tadalafil in the chronic prostatitis （Poster notice，General）
19.	2019/04/11	The application of color Doppler ultrasonography in patients with ejaculation dysfunction and a male volunteer with the squirting phenomenon after ejaculation: an update （Poster notice，General）
20.	2019/03/17	Therapeutic effect of tadalafil in the chronic prostatitis （Poster notice，General）
21.	2018/09/23	Laparoscopic adrenal-sparing surgery in pheochromocytoma associated with multiple endocrine neoplasia type 2A （Speech，General）
22.	2018/09/19	Therapeutic effect of indoleamine 2,3-dioxygenase (IDO) inhibitor in the male genital inflammation （Poster notice）
23.	2018/09/19	Therapeutic effect of indoleamine 2,3-dioxygenase (IDO) inhibitor in the male genital inflammation （Speech，General）
24.	2018/05/18	Risk of secondary bladder cancer after high dose rate brachytherapy for prostate cancer （Speech，General）
25.	2017/10/19	Prospective study of a switching GnRH agonist therapy in castration resistant prostate cancer in Japanese patients （Poster notice，General）
26.	2016/05/07	The role of indoleamine 2,3-dioxygenase in epididymitis （Speech，General）
27.	2016/03/12	The role of indoleamine 2,3-dioxygenase in epididymitis （Speech，General）
28.	2015/02	Evaluation of vascular endothelial function for patients with Erectile Dysfunction （Poster notice，General）
29.	2015/02	Maintenance of oral administration of anticholinergic drugs for overactive bladder （Poster notice，General）
30.	2014/09/04	Unilateral adrenalectomy followed by contralateral laparoscopic partial adrenalectomy for men 2a: A report of two cases （Speech，General）
31.	2013/03/16	Vasohibin-1 is a novel independent predictor of disease-free survival in curatively operated renal cell carcinoma patients （Poster notice，General）
32.	2013/02/14	Change of sexual functions in patients with benign prostatic hyperplasia after holmium laser enucleation of the prostate (HoLEP) （Poster notice，General）
33.	2013/02/14	Comparison of transperineal and transrectal 12-core initial prostate biopsy with PSA levels between 4.0 and 20.0 ng/ml （Speech，General）
34.	2012/10/01	Long-Term Compliance and Treatment Failure of alpha1-Blocker for Patients with Male Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia. （Poster notice，General）
35.	2012/09/07	Incidental Prostate Cancer in Holmium Laser Enucleation of the Prostate (HoLEP) （Poster notice，General）
36.	2012/09/05	Prognostic factors in subsequent development of bladder cancer after the surgical management of primary upper urinary tract urothelial carcinoma （Poster notice，General）
37.	2012/08/04	Evaluation of patients with symptoms of male andropause （Poster notice，General）
38.	2012/05/22	Improvement of sexual function in patients with benign prostatic hyperplasia treated by holmium laser enucleation of the prostate (HoLEP) （Speech，General）
39.	2012/05/21	Clinical efficacy of a new botulinum toxin type A free of complexing proteins in the treatment of refractory neurogenic and idiopathic detrusor overactivity （Poster notice，General）
40.	2012/04/23	Improvement of sexual function in patients with benign prostatic hyperplasia treated by holmium laser enucleation of the prostate (HoLEP) （Speech，General）
41.	2012/02/04	Use of Fuhrman grading system for Japanese patients with renal cell carcinoma （Poster notice，General）
42.	2011/10/29	Forty percent of patients with ureteral stones who visit the emergency room first are not followed by urologists. （Speech，General）
43.	2011/10/29	Health-Related Quality of Life in Patients with Localized Prostate Cancer Received High-Dose-Rate Brachytherapy: A Time-Course Analysis. （Speech）
44.	2011/10/29	Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after initial treatment. （Speech，General）
45.	2011/10/19	Correlation of Urinary Nerve Growth Factor Level With the Response of Antimuscarinic Therapy in Patients With Overactive Bladder （Poster notice，General）
46.	2011/10/18	Correlation with Urinary Epithelium and Primary Symptoms in Interstitial Cystitis: Inbestigation of Scannin Electron Microscopy （Poster notice，General）
47.	2011/10/18	Risk Factor Analysis of Patients’Dissatisfaction After Holmium LaserEnucleation of the Prostate (HoLEP)for Benign Prostatic Hyperplasia （Poster notice，General）
48.	2011/10/17	Efficacy of Transperineal Versus Transrectal 12-Core Initial Prostate Biopsy with PSA Levels Between 4.0 and 20.0 ng/ml （Speech，General）
49.	2011/10/17	Prognostic Factors and Survival of Renal Cell Carcinoma in Japanese Patients （Poster notice，General）
50.	2011/10/17	Retroperitoneal Dedifferentiated Liposarcoma with Production of Granulocyte Colony-Stimulating Factor (G-CSF) Accompanied by Spontaneous Rupture: PET/CT Imaging of a G-CSF-Producting Tumor （Poster notice，General）
Display 5 items
Display all(50)